Researcher
Innovation Center of Nanomedicine, Japan
I am a researcher committed to advancing therapeutic strategies for idiopathic pulmonary fibrosis (IPF) through the development of innovative nanomedicines. My work focuses on designing targeted drug delivery systems to overcome the limitations of current IPF treatments. I specialize in PROTAC-based nanomedicines and nanocarrier systems that enhance drug specificity and efficacy. By integrating molecular biology, pharmaceutical science, and nanotechnology, I aim to develop precision therapies that improve patient outcomes. My research contributes to the growing field of translational nanomedicine, with the ultimate goal of delivering safer and more effective treatments for chronic and hard-to-treat lung diseases like IPF.